You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Dow

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for International Business Machines Corporation v. Groupon, Inc. (D. Del. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

International Business Machines Corporation v. Groupon, Inc. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-03-02
Court District Court, D. Delaware Date Terminated 2018-10-02
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Plaintiff Referred To
Parties GO DADDY OPERATING COMPANY, LLC
Patents 10,036,037; 10,046,031; 10,047,033; 10,086,011; 6,255,054; 6,866,866; 7,078,020; 7,091,004; 8,039,010; 9,000,011; 9,005,056; 9,022,022; 9,056,051; 9,056,059; 9,254,257
Attorneys Adam M. Lewin
Firms Phillips, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in International Business Machines Corporation v. Groupon, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in International Business Machines Corporation v. Groupon, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for International Business Machines Corporation v. Groupon, Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2017-06-26 100 Transcript as well. That means "a second," 10:36:37 23 and "for presenting a plurality of.…'967 patent because IBM disclaimed the 09:10:02 10 advertising claims in that patent to take it…the way to finding that the 09:33:45 17 patent was patent eligible under Alice Step Two, found 09:33… 23 09:34:16 1 patentable, technological improvement are patent eligible. 09:34:20 2 …that is not what the 09:39:59 21 patents are doing. The patents are improving a system that 09:40 External link to document
2017-08-16 130 Exhibit 1-23 86:9, 86:10, 86:11, 92:22, 95:23…quot;Patents-In-Suit" means United States Patent Nos. 5,796,967 ("the '967 Patent"…quot;Patents-in-Suit" means United States Patent Nos. 5,796,967 ("the '967 Patent"…quot;Patents-In-Suit" means United States Patent Nos. 5,796,967 ("the '967 Patent"…5,961,601 ("the '601 Patent), 7,072,849 ("the '849 Patent"), and 7,631,346 (" External link to document
2018-03-27 263 Redacted Document from 1995 and 1996. (Ex. 8 at 209-212; Ex. 9 ¶¶ 254, 257; Weissman Depo. at 402:14-18, 404:20- 405:13…that the asserted claims of U.S. Patent No. 5,961,601 (the “’601 patent”) are not invalid. …OF THE ASSERTED CLAIMS OF U.S. PATENT NO. 5,961,601 … STATEMENT OF FACTS1 The ’601 patent is titled “Preserving State Information in a Continuing…communica- tions in the same conversation, the ’601 patent describes a method in which the server recursively External link to document
2018-09-18 408 Transcript the day. Tomorrow is a shorter day, just 9:00 11 until 1:00 p.m., so we won't be providing…substantively about 22 the '601 patent, she knows the patent, she knows the 23 inventors… 277 1 patent, it's not to substantively deal with the patent. 2 …18 papers and patents. Are you the inventor on any issued 19 patents? 20 A. … on 21 issued patents. 21 Q. And what is the general area of those patents? 22 External link to document
2018-09-26 428 Exhibit A-O S 6.096.51)4 8 6,255.54)) 8 (159.036) (2.5… griss billings S 6.255.54(1 8 6,237.832 8 …United States Patent Nos. 5,796,967 (the “’967 patent”), 7,072,849 (the “’849 patent”), 5,961,601 (…’601 patent”), and 7,631,346 (the “’346 patent”), collectively referred hereto as the “patents-in-suit… U.S. Patent No. 5,796,967 Prior Art Patents and Patent Applications External link to document
2017-06-06 94 Exhibit 1-11 licensee and patent holders of U.S. Patent Nos. 6,099,859 (“‘859") and 6,866,866 (“‘866"…used herein, “Patents-In-Suit” means United States Patent Nos. 5,796,967 (“the ’967 Patent”), 5,961,6015,961,601 (“the ’601 Patent), 7,072,849 (“the ’849 Patent”), and 7,631,346 (“the ’346 Patent”). 2. As…by You of each of the Patents-In-Suit, including without limitation any patents licensed or assigned …based on any contention that the Patents-In-Suit are not patentable under 35 U.S.C. 101, or for any other External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
McKesson
Medtronic
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.